Cooper, Keith https://orcid.org/0000-0002-0318-7670
Maund, Emma https://orcid.org/0000-0002-3998-6669
Takahashi, Marcia Tomie https://orcid.org/0000-0002-6932-2660
Shepherd, Jonathan https://orcid.org/0000-0003-1682-4330
Funding for this research was provided by:
Health Technology Assessment Programme (135558)
Article History
Accepted: 21 July 2024
First Online: 9 August 2024
Declarations
:
: All authors contributed to the critical review of the clinical and cost effectiveness evidence and drafting of the EAG report. KC wrote the first draft of this manuscript. All other authors reviewed and approved the final version.
: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Program (project number 135558) [see the NIHR Journals Library website for further information—]. The views and opinions expressed are the authors’ and do not necessarily reflect those of the HTA Programme, NICE, NIHR, NHS, or the Department of Health. Any errors are the responsibility of the authors. This summary of the ERG report was compiled after NICE issued the Final Appraisal Determination.
: Not applicable.
: Not applicable.
: All authors (KC, EM, MTT, JS) have no conflicts of interest.
: Not applicable.
: Not applicable.
: Not applicable.